An increment in canonical WNT signaling also characterizes the muscles of DMD patients, as disclosed by the quantification of known targets of the WNT signaling pathway (i.e., Axin2 and TGFβ2) in the interstitial space of human muscle biopsies (Appendix Fig S1B and C). The gene discussed is AXIN2; the disease is Duchenne muscular dystrophy.